PHARMExcel engages in key discussions at the 21st WORLD Symposium for rare disease research
PHARMExcel engages in key discussions at global rare disease research symposium.
PHARMExcel reports data for rare disease trials across 5 technologies
PHARMExcel reports on latest data for rare disease trials from 5 leading technologies.
PHARMExcel CEO to talk at Clinical Outsourcing Strategies Conference 2025
PHARMExcel CEO to talk at Clinical Outsourcing Strategies Conference 2025.
Engaging patient and advocates in rare disease clinical trials
Ways to engage patients and advocates in rare disease clinical trials.
PHARMExcel at 15: Looking Forward
Yvanne Enever, PHARMExcel CEO reflects on 15 years’ CRO success and what lies ahead for PHARMExcel, its clients and partners.
PHARMExcel named among the best CRO specialist providers
PHARMExcel receives honours for its clinical trial management services and partnerships.
PHARMExcel celebrates 15 years’ CRO impact in clinical trials for NHS, investigator and biotech research
Celebrating 15 years of delivering quality-driven clinical trials in the academic and commercial sector.
PHARMExcel awarded for impactful CRO services in ophthalmology clinical trials
High praise for the PHARMExcel team from the judges at the OBN Awards for exceptional services.
Why choose an ISO 9001-compliant CRO?
Is your CRO certified to ISO 9001 standards? Discover why this matters.